Arix Bioscience teams up with Takeda to invest in cancer drug developer VelosBio

03:36 EDT 1 Oct 2018 | Proactive Investors

Arix is investing US$11mln in VelosBio through a Series A funding round in return for an 11.2% stake in the company

More From BioPortfolio on "Arix Bioscience teams up with Takeda to invest in cancer drug developer VelosBio"